Tag: Squalamine Eye Drops for wet AMD awarded Fast Track designation by FDA

  • Squalamine Eye Drops for wet AMD awarded Fast Track designation by FDA

    The U.S. Food and Drug Administration (FDA) has seen fit to award Fast Track status to Ohr Pharmaceutical’s Squalamine Eye Drops, according to a press release detailing the situation. The press release noted that the biotechnology company’s promising drug got the FDA’s nod on account of its potential as a medication for those diagnosed with […]

121212121